158 related articles for article (PubMed ID: 36682962)
21. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic Approaches.
Gontero P; Marra G; Alessio P; Filippini C; Oderda M; Munoz F; Linares E; Sanchez-Salas R; Challacombe B; Dasgupta P; Goonewardene S; Popert R; Cahill D; Gillatt D; Persad R; Palou J; Joniau S; Piechaud T; Morlacco A; Vidit S; Rouprêt M; De La Taille A; Albisinni S; Gandaglia G; Mottrie A; Joshi S; Fiscus G; Berger A; Aron M; Van Der Poel H; Tilki D; Lawrentschuk N; Murphy DG; Leung G; Davis J; Karnes RJ;
J Urol; 2019 Oct; 202(4):725-731. PubMed ID: 31075058
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
[TBL] [Abstract][Full Text] [Related]
23. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
[TBL] [Abstract][Full Text] [Related]
24. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.
Trock BJ; Han M; Freedland SJ; Humphreys EB; DeWeese TL; Partin AW; Walsh PC
JAMA; 2008 Jun; 299(23):2760-9. PubMed ID: 18560003
[TBL] [Abstract][Full Text] [Related]
26. Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.
Gugliemetti G; Sukhu R; Conca Baenas MA; Meeks J; Sjoberg DD; Eastham JA; Scardino PT; Touijer K
Actas Urol Esp; 2016 Sep; 40(7):434-9. PubMed ID: 27184342
[TBL] [Abstract][Full Text] [Related]
27. European Association of Urology biochemical recurrence risk groups after radical prostatectomy: External validation and identification of independent risk factors for progression and death.
Sopeña Sutil R; Vázquez-Martul D; De Pablos-Rodríguez P; Peña Vallejo E; Altez Fernández C; Gómez-Ferrer Lozano A; Téigell Tobar J; Rollón Prieto G; Coy García A; Ramírez Backhaus M; Chantada Abal V; Rodríguez Antolín A
Actas Urol Esp (Engl Ed); 2023 Sep; 47(7):422-429. PubMed ID: 36746348
[TBL] [Abstract][Full Text] [Related]
28. Prostate Cancer-specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years' Report from the European Association of Urology Robotic Urology Section Scientific Working Group.
Falagario UG; Knipper S; Pellegrino F; Martini A; Akre O; Egevad L; Grönberg H; Moschovas MC; Bravi CA; Tran J; Heiniger Y; von Kempis A; Schaffar R; Carrieri G; Rochat CH; Mottrie A; Ahlering TE; John H; Patel V; Graefen M; Wiklund P;
Eur Urol Oncol; 2023 Sep; ():. PubMed ID: 37661459
[TBL] [Abstract][Full Text] [Related]
29. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
[TBL] [Abstract][Full Text] [Related]
30. Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review.
Marra G; Marquis A; Yanagisawa T; Shariat SF; Touijer K; Gontero P
Eur Urol Focus; 2023 Mar; 9(2):251-257. PubMed ID: 36822924
[TBL] [Abstract][Full Text] [Related]
31. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology.
Kang JJ; Reiter RE; Steinberg ML; King CR
Eur Urol Oncol; 2018 Oct; 1(5):378-385. PubMed ID: 31158076
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Clinical Recurrence of Node-positive Prostate Cancer and Impact on Long-term Survival.
Nini A; Gandaglia G; Fossati N; Suardi N; Cucchiara V; Dell'Oglio P; Cazzaniga W; Luzzago S; Montorsi F; Briganti A
Eur Urol; 2015 Nov; 68(5):777-84. PubMed ID: 25959166
[TBL] [Abstract][Full Text] [Related]
33. Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought.
Bravi CA; Fossati N; Gandaglia G; Suardi N; Mazzone E; Robesti D; Osmonov D; Juenemann KP; Boeri L; Jeffrey Karnes R; Kretschmer A; Buchner A; Stief C; Hiester A; Nini A; Albers P; Devos G; Joniau S; Van Poppel H; Shariat SF; Heidenreich A; Pfister D; Tilki D; Graefen M; Gill IS; Mottrie A; Karakiewicz PI; Montorsi F; Briganti A
Eur Urol; 2020 Nov; 78(5):661-669. PubMed ID: 32624288
[TBL] [Abstract][Full Text] [Related]
34. Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence.
Malik RD; Goldberg JD; Hochman T; Lepor H
Eur Urol; 2011 Sep; 60(3):548-53. PubMed ID: 21652145
[TBL] [Abstract][Full Text] [Related]
35. Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen-radioguided Surgery.
Knipper S; Mehdi Irai M; Simon R; Koehler D; Rauscher I; Eiber M; van Leeuwen FWB; van Leeuwen P; de Barros H; van der Poel H; Budäus L; Steuber T; Graefen M; Tennstedt P; Heck MM; Horn T; Maurer T
Eur Urol; 2023 Jan; 83(1):62-69. PubMed ID: 35718637
[TBL] [Abstract][Full Text] [Related]
36. Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complications.
Rosoff JS; Savage SJ; Prasad SM
World J Urol; 2013 Dec; 31(6):1347-52. PubMed ID: 23358790
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy.
Gandaglia G; Bravi CA; Dell'Oglio P; Mazzone E; Fossati N; Scuderi S; Robesti D; Barletta F; Grillo L; Maclennan S; N'Dow J; Montorsi F; Briganti A
Eur Urol; 2018 Jul; 74(1):4-7. PubMed ID: 29544735
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Van den Broeck T; van den Bergh RCN; Arfi N; Gross T; Moris L; Briers E; Cumberbatch M; De Santis M; Tilki D; Fanti S; Fossati N; Gillessen S; Grummet JP; Henry AM; Lardas M; Liew M; Rouvière O; Pecanka J; Mason MD; Schoots IG; van Der Kwast TH; van Der Poel HG; Wiegel T; Willemse PM; Yuan Y; Lam TB; Cornford P; Mottet N
Eur Urol; 2019 Jun; 75(6):967-987. PubMed ID: 30342843
[TBL] [Abstract][Full Text] [Related]
39. A contemporary analysis of disease upstaging of Gleason 3 + 3 prostate cancer patients after robot-assisted laparoscopic prostatectomy.
Taggart R; Dutto L; Leung HY; Salji M; Ahmad I
Cancer Med; 2023 Nov; 12(22):20830-20837. PubMed ID: 37929881
[TBL] [Abstract][Full Text] [Related]
40. Validation of the STAR-CAP Clinical Prognostic System for Predicting Biochemical Recurrence, Metastasis, and Cancer-specific Mortality After Radical Prostatectomy in a European Cohort.
Würnschimmel C; Pose RM; Wenzel M; Tian Z; Incesu RB; Karakiewicz P; Graefen M; Tilki D
Eur Urol; 2021 Oct; 80(4):400-404. PubMed ID: 34162491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
